| Customization: | Available |
|---|---|
| CAS No.: | Customization, 162012-67-1 |
| Formula: | Customization |
|
Still deciding? Get samples of US$ 1/Piece
Order Sample
|
| Shipping Cost: | Contact the supplier about freight and estimated delivery time. |
|---|
| Payment Methods: |
|
|---|---|
| Support payments in USD |
| Secure payments: | Every payment you make on Made-in-China.com is protected by the platform. |
|---|
| Refund policy: | Claim a refund if your order doesn't ship, is missing, or arrives with product issues. |
|---|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
N-(4-(3-chloro-4-fluorophenyl))-7-fluoro-6-nitroquinazolin-4-amine, commonly known as 3C4F-NFQ, is a chemical compound that belongs to the quinazolin-4-amine family. With its unique molecular structure, it possesses various potential applications and beneficial properties.
In terms of its structure, 3C4F-NFQ consists of a quinazolin-4-amine core with a substituted phenyl group and nitro functional groups attached. This combination of chemical groups gives 3C4F-NFQ its distinctive properties.
In terms of its potential benefits, 3C4F-NFQ has shown promising results in preclinical studies as an anticancer agent. It exhibits potent cytotoxic activity against certain cancer cell lines, inhibiting their growth and proliferation. The compound's mechanism of action involves targeting specific molecular pathways within cancer cells, leading to apoptosis (cell death) and suppression of tumor growth.
Furthermore, due to its unique molecular structure, 3C4F-NFQ has also demonstrated potential as an anti-inflammatory agent. It has been shown to inhibit the production of inflammatory mediators, providing relief from inflammation-related conditions.
ApplicationIn conclusion, N-(4-(3-chloro-4-fluorophenyl))-7-fluoro-6-nitroquinazolin-4-amine (3C4F-NFQ) is a chemical compound with significant potential as an anticancer and anti-inflammatory agent. Its unique molecular structure and promising preclinical results make it a candidate for further research and development in the field of oncology and inflammation-related disorders.
){kind=link}